Výsledky vyhledávání - "Emad R Issak"

Akademický článek

Oral semaglutide effectiveness and safety in real world practice; The REVOLUTION study

Autor: Abdulrahman Alsheikh, Ali Alshehri, Saad Alzahrani, Anwar AlJammah, Fahad Alqahtani, Metib Alotaibi, Raed Aldahash, Amani M. Alhozali, Fahad Alsabaan, Mohammed Almehthel, Naser Aljuhani, Ali Aldabeis, Moneer Alamri, Waleed Maghawry, Naweed Alzaman, Alshaima Alshaikh, Omar M. Alnozha, Emad R Issak, Saud Alsifri

Publikováno v: Diabetes Epidemiology and Management, Vol 14, Iss , Pp 100209- (2024)

Aims: This study seeks to provide insights into the practical application and effects of oral semaglutide in Saudi T2DM patients under routine medical supervision. Methods: The primary outcome measure was the laboratory HbA1c. Secondary measures incl

Externí odkaz: https://doaj.org/article/6699110421344ee2862ec94dedf8633d

Zobrazit plný text záznamu

Akademický článek

Timing of corticosteroids in non-severe non-hospitalized COVID-19 patients: open-label, two-center, randomized controlled study (TICS-COV19 study)

Autor: Emad R. Issak, Mariam M. Amin

Publikováno v: The Korean Journal of Internal Medicine, Vol 38, Iss 2, Pp 207-217 (2023)

Background/Aims Corticosteroids (CSs) are frequently used in coronavirus disease 2019 (COVID-19); however, their utility remains controversial in mild to moderate cases. The timing of CSs initiation during the disease course remains unaddressed. The

Externí odkaz: https://doaj.org/article/609e37b1954c4c42855324810a241b4a

Zobrazit plný text záznamu

Akademický článek

Efficacy of growth hormone supplementation with ultrashort GnRH antagonist in IVF/ICSI for poor responders; randomized controlled trial

Autor: Ehab H. Mohammad, Ahmed G. Abou El Serour, Eman A.H. Mohamed, Amr H. Abbasy, Mahmoud Zaatar, Kamal A. Rageh, Mohamed M. Shafeek, Emad R. Issak

Publikováno v: Taiwanese Journal of Obstetrics & Gynecology, Vol 60, Iss 1, Pp 51-55 (2021)

Objectives: To compare the ICSI-ET outcomes in poor responders who underwent ovarian stimulation by the ultrashort GnRH antagonist protocol with or without adjuvant GH injection. Material and methods: This randomized controlled study was conducted at

Externí odkaz: https://doaj.org/article/bc719c4e671e404a95960a69fb45b07d

Zobrazit plný text záznamu

Egyptian Atherosclerosis and Vascular Biology Association Consensus on the Use of Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction

Autor: Ihab Attia, Hazem Khamis, Ahmed Elkersh, Atef Elbahry, Osama Sanad, Elsayed Farag, Ashraf Reda, Ahmed Bendary, Ahmed Shawky Elserafy, Nabil Farag, Mohammed Selim, Tamer Mostafa, Emad R. Issak

Publikováno v: Clinical Drug Investigation

Heart failure (HF) is a common cause of cardiovascular mortality and morbidity. Despite advances in treatment, the prognosis remains poor. Sodium-glucose co-transporter 2 (SGLT-2) inhibitors decrease HF events by 27–39% in high-risk patients with t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b57314b7b4d92c4a9977a27f907de0dc
https://doi.org/10.1007/s40261-021-01095-6

Zobrazit plný text záznamu

Saudi Consensus for Low-Premixed Insulin Analogues in Type 2 Diabetes: Consensus Report

Autor: Fahad Alsabaan, Turky Alharbi, Mohammed Almuzaini, Emad R. Issak, Samia Bokhari, Saud Alsifri, Khalid Alyahya, Abdulaziz Bin Shaikh, Mohammed S. Aljamal, Abdulrahman Alshaikh, Ali M. Alrumaih, Rashid Aljuwair

Publikováno v: International Journal of Clinical Medicine. 12:165-182

Dear Dr. Martin Hovland, We learned from the literature that premixed insulins are short-acting insulin or rapid-acting insulin analogue mixed with intermediate-acting insulin in a fixed ratio, addressing FBG and PPBG in one injection. There are two

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6d1562f1a0e0dadcc3fee5da97d01ac6
https://doi.org/10.4236/ijcm.2021.124016

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání